Plasma Soluble Urokinase Plasminogen Activator Receptor in Children with Urinary Tract Infection

Plasma Soluble Urokinase Plasminogen Activator Receptor in Children with Urinary Tract Infection

Show other versions (1)

Bibliographic Details
Main Authors:	Per Wittenhagen, Jesper Brandt Andersen, Anita Hansen, Lone Lindholm, Frederik Rønne, Jørn Theil, Michael Tvede, Jesper Eugen-Olsen
Format:	Article
Language:	English
Published:	SAGE Publishing 2011-08-01
Series:	Biomarker Insights
Online Access:	http://www.la-press.com/plasma-soluble-urokinase-plasminogen-activator-receptor-in-children-wi-a2801

Similar Items

Plasma Soluble Urokinase Plasminogen Activator Receptor in Children with Urinary Tract Infection
by: Per Wittenhagen, et al.
Published: (2011-01-01)

Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
by: Nina S. Godtfredsen, et al.
Published: (2018-05-01)

Serum soluble urokinase plasminogen activator receptor (suPAR) in adults with growth hormone deficiency
by: Charlotte Höybye, et al.
Published: (2019-05-01)

Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor
by: Viktor Rotbain Curovic, et al.
Published: (2022-04-01)

Association of soluble urokinase plasminogen activator receptor levels with fibrotic and vascular manifestations in systemic sclerosis.
by: Sheraz Butt, et al.
Published: (2021-01-01)

Risk Factors Associated with Serum Levels of the Inflammatory Biomarker Soluble Urokinase Plasminogen Activator Receptor in a General Population
by: Thomas H. Haupt, et al.
Published: (2014-12-01)

Risk Factors Associated with Serum Levels of the Inflammatory Biomarker Soluble Urokinase Plasminogen Activator Receptor in a General Population
by: Thomas H. Haupt, et al.
Published: (2014-01-01)

Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19
by: Shengyuan Luo, et al.
Published: (2022-09-01)

Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis.
by: Emilie Garnæs, et al.
Published: (2019-01-01)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin′s Lymphoma
by: Shirin Kouhpayeh, et al.
Published: (2017-01-01)

Extracellular matrix biomarker, fibulin-1, is closely related to NT-proBNP and soluble urokinase plasminogen activator receptor in patients with aortic valve stenosis (the SEAS study).
by: Ruan Kruger, et al.
Published: (2014-01-01)

Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis
by: George Hindy, et al.
Published: (2022-12-01)

Soluble urokinase plasminogen activator receptor for the prediction of ventilator-associated pneumonia
by: Pouline M. van Oort, et al.
Published: (2019-03-01)

Circulating Soluble Urokinase-Type Plasminogen Activator Receptor in Obstructive Sleep Apnoea
by: Renata Marietta Bocskei, et al.
Published: (2020-02-01)

Soluble urokinase plasminogen activator receptor (suPAR) in the emergency department: An update
by: Dimitrios Velissaris, et al.
Published: (2022-09-01)

The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia
by: Nergiz Erkut, et al.
Published: (2016-05-01)

TISSUE PLASMINOGEN-ACTIVATOR VERSUS UROKINASE
by: Ebers, G
Published: (1988)

Neuroprotection by urokinase plasminogen activator in the hippocampus
by: Eunsil Cho, et al.
Published: (2012-04-01)

Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screening.
by: Kjellman, A, et al.
Published: (2011)

Detection of soluble urokinase type plasminogen activator receptors in children with gingivitis and normal subjects
by: Mohamed Abd‑Ellatif El‑Patal, et al.
Published: (2022-10-01)

Serum soluble urokinase plasminogen activator receptor in adolescents: interaction of chronic pain and obesity
by: Hershel Raff, et al.
Published: (2020-08-01)

Association between serum soluble urokinase-type plasminogen activator receptor and atrial fibrillation
by: Noboru Ichihara, et al.
Published: (2017-10-01)

Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer
by: Sven H. Loosen, et al.
Published: (2020-04-01)

Soluble Urokinase Plasminogen Activator Receptor (SuPAR) Analysis for Diagnosis of Periprosthetic Joint Infection
by: Sebastian M. Klim, et al.
Published: (2024-02-01)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies
by: Burcin Özdirik, et al.
Published: (2020-05-01)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases
by: Mariangela Manfredi, et al.
Published: (2023-04-01)

Soluble urokinase plasminogen activator receptor: from biomarker to active participant in atherosclerosis and cardiovascular disease
by: Traci T. Goodchild, et al.
Published: (2022-12-01)

Soluble urokinase plasminogen activation receptor - An emerging new biomarker of cardiovascular disease and critical illness
by: Nicole B Cyrille, et al.
Published: (2016-01-01)

Soluble urokinase-type plasminogen activator receptor as a biomarker of treatment response in childhood tuberculosis
by: Ery Olivianto, et al.
Published: (2019-01-01)

Predictive value of soluble urokinase-type plasminogen activator receptor in patients with severe acute pancreatitis
by: LI Yang, et al.
Published: (2022-02-01)

The Diagnostic Accuracy of Procalcitonin, Soluble Urokinase-Type Plasminogen Activator Receptors, and C-Reactive Protein in Diagnosing Urinary Tract Infections in the Emergency Department—A Diagnostic Accuracy Study
by: Mathias Amdi Hertz, et al.
Published: (2024-03-01)

Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
by: Ran Zhu, et al.
Published: (2022-08-01)

The Soluble Urokinase-Type Plasminogen Activator Receptor as a Biomarker for Survival and Early Treatment Effect in Metastatic Colorectal Cancer
by: Kristian Blomberg, et al.
Published: (2021-10-01)

Soluble urokinase plasminogen activator receptor levels predict survival in patients with portal hypertension undergoing TIPS
by: Sven H. Loosen, et al.
Published: (2024-05-01)

Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated with Severity of Fibrosis in Patients with Primary Sclerosing Cholangitis
by: Burcin Özdirik, et al.
Published: (2022-04-01)

The accuracy of soluble urokinase-type plasminogen activator receptor for the diagnosis of neonatal sepsis: a meta-analysis
by: Jinjin Ma, et al.
Published: (2023-04-01)

Soluble urokinase plasminogen activator receptor (suPAR) and glomerular disease in children: a narrative review
by: Phuong Anh Le Thy, et al.
Published: (2022-09-01)

Soluble urokinase-type plasminogen activator receptor as a measure of treatment response in acute exacerbation of COPD
by: Gehan Hassan AboEl-Magd, et al.

Value of soluble Urokinase plasminogen activator receptor over age as a biomarker of impaired myocardial relaxation
by: Koh, Angela S., et al.
Published: (2018)

Value of soluble Urokinase plasminogen activator receptor over age as a biomarker of impaired myocardial relaxation
by: Angela S. Koh, et al.
Published: (2017-11-01)